SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001178913-24-003147 from Evogene Ltd. (EVGN)

Evogene Ltd.
Date: Sept. 25, 2024 · CIK: 0001574565 · Accession: 0001178913-24-003147

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-282218

Date
September 25, 2024
Author
EVOGENE LTD.
Form
CORRESP
Company
Evogene Ltd.

Letter

VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Industrial Applications and Services Attention: Conlon Danberg Evogene Ltd. Registration Statement on Form F-1 Filed September 19, 2024 File No. 333-282218

Dear Mr. Danberg:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Evogene Ltd. hereby requests that the effective date of the above-referenced Registration Statement on Form F-1 be accelerated so that it will become effective at 9:00 a.m. Eastern time on September 27, 2024, or as soon as practicable thereafter.

Please contact our outside counsel, Meitar Law Offices (Mike Rimon, Adv. at +972-3-6145822 or mrimon@meitar.com, Jonathan M. Nathan, Adv. at +972-3-610-3157 or jonathann@meitar.com, or Elad Ziv, Adv. at+972-3-6142613 or eladz@meitar.com) with any questions, and please notify them when this request for acceleration has been granted.

Sincerely,
EVOGENE LTD.

Show Raw Text
CORRESP
1
filename1.htm

    Evogene Ltd.

    13 Gad Feinstein Street, Park Rehovot

    Rehovot 7638517, Israel

    September 25, 2024

    VIA EDGAR

    United States Securities and Exchange Commission

      Division of Corporation Finance

    Office of Industrial Applications and Services

      100 F Street, N.E.

      Washington, D.C. 20549

      Attention: Conlon Danberg

            Re:

            Evogene Ltd.

            Registration Statement on Form F-1

            Filed September 19, 2024

            File No. 333-282218

    Dear Mr. Danberg:

    Pursuant to Rule 461 under the Securities Act of 1933, as amended, Evogene Ltd. hereby requests that the effective date of the above-referenced Registration Statement on Form F-1 be accelerated so that
      it will become effective at 9:00 a.m. Eastern time on September 27, 2024, or as soon as practicable thereafter.

    Please contact our outside counsel, Meitar Law Offices (Mike Rimon, Adv. at +972-3-6145822 or mrimon@meitar.com, Jonathan M. Nathan, Adv. at +972-3-610-3157 or jonathann@meitar.com, or
      Elad Ziv, Adv. at+972-3-6142613 or eladz@meitar.com) with any questions, and please notify them when this request for acceleration has been granted.

            Sincerely,

            EVOGENE LTD.

            By:

            /s/ Ofer Haviv

            Name: Ofer Haviv

            Title: President and Chief Executive Officer

            cc:

            Meitar Law Offices

              Mike Rimon, Adv.

              Jonathan M. Nathan, Adv.

              Elad Ziv, Adv.